{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T03:00:22Z","timestamp":1765422022514},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T00:00:00Z","timestamp":1504137600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00393-017-0372-7","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T12:05:02Z","timestamp":1504181102000},"page":"673-681","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Augenbeteiligung bei rheumatoider Arthritis, Kollagenosen und Vaskulitiden"],"prefix":"10.1007","volume":"76","author":[{"given":"I.","family":"K\u00f6tter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"St\u00fcbiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Deuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,31]]},"reference":[{"key":"372_CR1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrrheum.2013.185","volume":"10","author":"M Artifoni","year":"2014","unstructured":"Artifoni M, Rothschild PR, Brezin A et\u00a0al (2014) Ocular inflammatory diseases associated with rheumatoid arthritis. Nat Rev Rheumatol 10:108\u2013116","journal-title":"Nat Rev Rheumatol"},{"key":"372_CR2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1750-1172-7-57","volume":"7","author":"T Barisani-Asenbauer","year":"2012","unstructured":"Barisani-Asenbauer T, Maca SM, Mejdoubi L et al (2012) Uveitis \u2013 a\u00a0rare disease often associated with systemic diseases and infections \u2013 a\u00a0systematic review of 2619 patients. Orphanet J Rare Dis 7:57","journal-title":"Orphanet J Rare Dis"},{"key":"372_CR3","doi-asserted-by":"crossref","first-page":"e4218","DOI":"10.1097\/MD.0000000000004218","volume":"95","author":"A Chen","year":"2016","unstructured":"Chen A, Chen HT, Hwang YH et al (2016) Severity of dry eye syndrome is related to anti-dsDNA autoantibody in systemic lupus erythematosus patients without secondary Sjogren syndrome: A cross-sectional analysis. Medicine (Baltimore) 95:e4218","journal-title":"Medicine (Baltimore)"},{"key":"372_CR4","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1002\/art.27581","volume":"62","author":"CM Deuter","year":"2010","unstructured":"Deuter CM, Zierhut M, Mohle A et al (2010) Long-term remission after cessation of interferon-alpha treatment in patients with severe uveitis due to Behcet\u2019s disease. Arthritis Rheum 62:2796\u20132805","journal-title":"Arthritis Rheum"},{"key":"372_CR5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00393-009-0577-5","volume":"69","author":"E Feist","year":"2010","unstructured":"Feist E, Pleyer U (2010) Diseases of the outer eye in rheumatoid arthritis. Z\u00a0Rheumatol 69:403\u2013410","journal-title":"Z Rheumatol"},{"key":"372_CR6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/sarh.2001.16639","volume":"30","author":"F Hamideh","year":"2001","unstructured":"Hamideh F, Prete PE (2001) Ophthalmologic manifestations of rheumatic diseases. Semin Arthritis Rheum 30:217\u2013241","journal-title":"Semin Arthritis Rheum"},{"key":"372_CR7","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/ard.2007.080432","volume":"67","author":"G Hatemi","year":"2008","unstructured":"Hatemi G, Silman A, Bang D et\u00a0al (2008) EULAR recommendations for the management of Behcet disease. Ann Rheum Dis 67:1656\u20131662","journal-title":"Ann Rheum Dis"},{"key":"372_CR8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000321947","volume":"46","author":"A Heiligenhaus","year":"2011","unstructured":"Heiligenhaus A, Wefelmeyer D, Wefelmeyer E et\u00a0al (2011) The eye as a\u00a0common site for the early clinical manifestation of sarcoidosis. Ophthalmic Res 46:9\u201312","journal-title":"Ophthalmic Res"},{"key":"372_CR9","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","volume":"116","author":"GS Hoffman","year":"1992","unstructured":"Hoffman GS, Kerr GS, Leavitt RY et\u00a0al (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488\u2013498","journal-title":"Ann Intern Med"},{"key":"372_CR10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.17116\/terarkh201789569-73","volume":"89","author":"DS Ismailova","year":"2017","unstructured":"Ismailova DS, Novikov PI, Grusha YO et\u00a0al (2017) The frequency of ophthalmologic manifestations of granulomatosis with polyangiitis (Wegener\u2019s) and their relationship to systemic diseases. Ter Arkh 89:69\u201373","journal-title":"Ter Arkh"},{"key":"372_CR11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3899\/jrheum.080102","volume":"36","author":"E Jakob","year":"2009","unstructured":"Jakob E, Reuland MS, Mackensen F et\u00a0al (2009) Uveitis subtypes in a\u00a0german interdisciplinary uveitis center \u2013 analysis of 1916 patients. J\u00a0Rheumatol 36:127\u2013136","journal-title":"J Rheumatol"},{"key":"372_CR12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1755-3768.2008.01314.x","volume":"87","author":"A Kawasaki","year":"2009","unstructured":"Kawasaki A, Purvin V (2009) Giant cell arteritis: an updated review. Acta Ophthalmol 87:13\u201332","journal-title":"Acta Ophthalmol"},{"key":"372_CR13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.rdc.2010.05.005","volume":"36","author":"AA Kubal","year":"2010","unstructured":"Kubal AA, Perez VL (2010) Ocular manifestations of ANCA-associated vasculitis. Rheum Dis Clin North Am 36:573\u2013586","journal-title":"Rheum Dis Clin North Am"},{"key":"372_CR14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1191\/0961203306lu2250rr","volume":"15","author":"V Peponis","year":"2006","unstructured":"Peponis V, Kyttaris VC, Tyradellis C et\u00a0al (2006) Ocular manifestations of systemic lupus erythematosus: a\u00a0clinical review. Lupus 15:3\u201312","journal-title":"Lupus"},{"key":"372_CR15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.semarthrit.2012.08.003","volume":"42","author":"PR Rothschild","year":"2013","unstructured":"Rothschild PR, Pagnoux C, Seror R et\u00a0al (2013) Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a\u00a0retrospective study of 1286 patients and review of the literature. Semin Arthritis Rheum 42:507\u2013514","journal-title":"Semin Arthritis Rheum"},{"key":"372_CR16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/bjophthalmol-2015-306629","volume":"100","author":"S Silpa-Archa","year":"2016","unstructured":"Silpa-Archa S, Lee JJ, Foster CS (2016) Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol 100:135\u2013141","journal-title":"Br J Ophthalmol"},{"key":"372_CR17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ncprheum0454","volume":"3","author":"JR Smith","year":"2007","unstructured":"Smith JR, Mackensen F, Rosenbaum JT (2007) Therapy insight: scleritis and its relationship to systemic autoimmune disease. Nat Clin Pract Rheumatol 3:219\u2013226","journal-title":"Nat Clin Pract Rheumatol"},{"key":"372_CR18","first-page":"Abstract 911","volume":"68","author":"JHT Stone","year":"2016","unstructured":"Stone JHT, Dimonaco K, Klearmanm S, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Spiera RF, Unizony SH, Collinson N, Giacta Investigators (2016) Efficacy and safety of tocilizumab in patients with giant cell arteritis: primary and secondary outcomes from a\u00a0phase 3, randomized, doulble-blind, placebo-controlled trial. Arthritis Rheum 68:Abstract 911","journal-title":"Arthritis Rheum"},{"key":"372_CR19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ophtha.2012.09.050","volume":"120","author":"A Stylianides","year":"2013","unstructured":"Stylianides A, Jones MN, Stewart RM et al (2013) Rheumatoid arthritis-associated corneal ulceration: mortality and graft survival. Ophthalmology 120:682\u2013686","journal-title":"Ophthalmology"},{"key":"372_CR20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.survophthal.2009.12.003","volume":"55","author":"AB Tarabishy","year":"2010","unstructured":"Tarabishy AB, Schulte M, Papaliodis GN et\u00a0al (2010) Wegener\u2019s granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic disease. Surv Ophthalmol 55:429\u2013444","journal-title":"Surv Ophthalmol"},{"key":"372_CR21","first-page":"393","volume":"9","author":"AP Vignesh","year":"2015","unstructured":"Vignesh AP, Srinivasan R (2015) Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies. Clin Ophthalmol 9:393\u2013397","journal-title":"Clin Ophthalmol"},{"key":"372_CR22","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(16)00560-2","volume":"387","author":"PM Villiger","year":"2016","unstructured":"Villiger PM, Adler S, Kuchen S et al (2016) Tocilizumab for induction and maintenance of remission in giant cell arteritis: a\u00a0phase 2, randomised, double-blind, placebo-controlled trial. Lancet 387:1921\u20131927","journal-title":"Lancet"},{"key":"372_CR23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12177-009-9044-4","volume":"3","author":"AS Watkins","year":"2009","unstructured":"Watkins AS, Kempen JH, Choi D et al (2009) Ocular disease in patients with ANCA-positive vasculitis. J\u00a0Ocul Biol Dis Infor 3:12\u201319","journal-title":"J Ocul Biol Dis Infor"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-017-0372-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-017-0372-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-017-0372-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:23:24Z","timestamp":1570062204000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-017-0372-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,31]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["372"],"URL":"https:\/\/doi.org\/10.1007\/s00393-017-0372-7","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,31]]}}}